drugset / Trial / NCT00044824

Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma

NCT00044824

Phase 3 Completed 1000 enrolled Sanofi
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to investigate the efficacy and safety of fexofenadine 120mg BID compared to placebo in the treatment of subjects with mild to moderate persistent asthma

Timeline

Start
2002-02
Primary completion
2003-10
Completion
2003-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Fexofenadine Unknown 120 mg

Indications